Literature DB >> 21994406

Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.

Sabina Rinaldi1, Martyn Plummer, Carine Biessy, Xavier Castellsagué, Kim Overvad, Susanne Krüger Kjær, Anne Tjønneland, Françoise Clavel-Chapelon, Nathalie Chabbert-Buffet, Sylvie Mesrine, Annekatrin Lukanova, Rudolf Kaaks, Cornelia Weikert, Heiner Boeing, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Claudia Agnoli, Rosario Tumino, Paolo Vineis, Salvatore Panico, Bas Bueno-de-Mesquita, Henk J van Kranen, Petra Hm Peeters, Kjersti Bakken, Eiliv Lund, Inger Torhild Gram, Laudina Rodríguez, F Xavier Bosch, Maria-José Sánchez, Miren Dorronsoro, Carmen Navarro, Aurelio Barricarte Gurrea, Lennart Kjellberg, Joakim Dillner, Jonas Manjer, Salma Butt, Kay-Tee Khaw, Nicholas Wareham, Naomi E Allen, Ruth Travis, Isabelle Romieu, Pietro Ferrari, Elio Riboli, Silvia Franceschi.   

Abstract

BACKGROUND: Epidemiologic data and animal models suggest that, despite the predominant role of human papillomavirus infection, sex steroid hormones are also involved in the etiology of invasive cervical carcinoma (ICC).
METHODS: Ninety-nine ICC cases, 121 cervical intraepithelial neoplasia grade 3 (CIN3) cases and 2 control women matched with each case for center, age, menopausal status and blood collection-related variables, were identified in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Circulating levels of testosterone (T) and estradiol (E(2)); dehydroepiandrosterone sulfate (DHEAS); progesterone (premenopausal women); and sex hormone-binding globulin (SHBG) were measured using immunoassays. Levels of free (f) T and E(2) were calculated from absolute concentrations of T, E(2), and SHBG. Odds ratios (ORs) and 95% confidence intervals (CI) were computed using regularized conditional logistic regression.
RESULTS: Among premenopausal women, associations with ICC were observed for fT (OR for highest vs. lowest tertile = 5.16, 95% CI, 1.50-20.1). SHBG level was associated with a significant downward trend in ICC risk. T, E(2), fE(2), and DHEAS showed nonsignificant positive association with ICC. Progesterone was uninfluential. Among postmenopausal women, associations with ICC were found for T (OR = 3.14; 95% CI, 1.21-9.37), whereas E(2) and fT showed nonsignificant positive association. SHBG level was unrelated to ICC risk in postmenopausal women. No associations between any hormone and CIN3 were detected in either pre- or postmenopausal women.
CONCLUSIONS: Our findings suggest for the first time that T and possibly E(2) may be involved in the etiology of ICC. IMPACT: The responsiveness of cervical tumors to hormone modulators is worth exploring.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994406     DOI: 10.1158/1055-9965.EPI-11-0753

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

1.  Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study.

Authors:  Tess V Clendenen; Kathryn Hertzmark; Karen L Koenig; Eva Lundin; Sabina Rinaldi; Theron Johnson; Vittorio Krogh; Göran Hallmans; Annika Idahl; Annekatrin Lukanova; Anne Zeleniuch-Jacquotte
Journal:  Horm Cancer       Date:  2016-02-29       Impact factor: 3.869

2.  Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy.

Authors:  Megan E Spurgeon; Sang-Hyuk Chung; Paul F Lambert
Journal:  Am J Pathol       Date:  2014-02       Impact factor: 4.307

Review 3.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 4.  Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.

Authors:  Matthias Läsche; Julia Gallwas; Carsten Gründker
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

5.  17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

Authors:  Anna Lutkowska; Andrzej Roszak; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

6.  Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.

Authors:  Megan E Spurgeon; Johan A den Boon; Mark Horswill; Sonalee Barthakur; Omid Forouzan; Janet S Rader; David J Beebe; Avtar Roopra; Paul Ahlquist; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

7.  Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.

Authors:  Jieun Son; Jung Wook Park; Paul F Lambert; Sang-Hyuk Chung
Journal:  Carcinogenesis       Date:  2013-10-22       Impact factor: 4.944

Review 8.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

9.  Past and future of prophylactic ablation of the cervical squamocolumnar junction.

Authors:  Silvia Franceschi
Journal:  Ecancermedicalscience       Date:  2015-04-29

10.  The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

Authors:  Esther Roura; Noémie Travier; Tim Waterboer; Silvia de Sanjosé; F Xavier Bosch; Michael Pawlita; Valeria Pala; Elisabete Weiderpass; Núria Margall; Joakim Dillner; Inger T Gram; Anne Tjønneland; Christian Munk; Domenico Palli; Kay-Tee Khaw; Kim Overvad; Françoise Clavel-Chapelon; Sylvie Mesrine; Agnès Fournier; Renée T Fortner; Jennifer Ose; Annika Steffen; Antonia Trichopoulou; Pagona Lagiou; Philippos Orfanos; Giovanna Masala; Rosario Tumino; Carlotta Sacerdote; Silvia Polidoro; Amalia Mattiello; Eiliv Lund; Petra H Peeters; H B as Bueno-de-Mesquita; J Ramón Quirós; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Nerea Larrañaga; Johanna Ekström; David Lindquist; Annika Idahl; Ruth C Travis; Melissa A Merritt; Marc J Gunter; Sabina Rinaldi; Massimo Tommasino; Silvia Franceschi; Elio Riboli; Xavier Castellsagué
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.